1. Home
  2. GSBC vs ANNX Comparison

GSBC vs ANNX Comparison

Compare GSBC & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Great Southern Bancorp Inc.

GSBC

Great Southern Bancorp Inc.

N/A

Current Price

$79.49

Market Cap

862.6M

Sector

Finance

ML Signal

N/A

Logo Annexon Inc.

ANNX

Annexon Inc.

N/A

Current Price

$4.67

Market Cap

873.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GSBC
ANNX
Founded
1923
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
862.6M
873.3M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
GSBC
ANNX
Price
$79.49
$4.67
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$65.00
$16.50
AVG Volume (30 Days)
76.1K
2.3M
Earning Date
04-15-2026
05-11-2026
Dividend Yield
2.54%
N/A
EPS Growth
17.68
N/A
EPS
2.99
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.56
$16,320.74
P/E Ratio
$26.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$53.76
$2.32
52 Week High
$82.91
$7.18

Technical Indicators

Market Signals
Indicator
GSBC
ANNX
Relative Strength Index (RSI) 53.37 37.57
Support Level $76.29 $4.01
Resistance Level $82.19 $5.63
Average True Range (ATR) 1.49 0.24
MACD 0.04 -0.03
Stochastic Oscillator 73.46 3.76

Price Performance

Historical Comparison
GSBC
ANNX

About GSBC Great Southern Bancorp Inc.

Great Southern Bancorp Inc is a bank holding company. Through its subsidiaries, the company mainly offers a variety of banking and banking-related services, such as accepting deposits, granting loans and advances, offering mobile banking services, issuing debit and credit cards, safe deposit boxes, ATM facilities, and other related products and services. These services are offered through full-service retail banking offices and loan production offices located across different states in the U.S., including Missouri, Iowa, Kansas, Minnesota, Nebraska, Arkansas, and others.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: